Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 24.56M P/E - EPS this Y - Ern Qtrly Grth -
Income -6.35M Forward P/E 3.74 EPS next Y - 50D Avg Chg 2.00%
Sales 5.41M PEG - EPS past 5Y 24.07% 200D Avg Chg -39.00%
Dividend N/A Price/Book 3.29 EPS next 5Y - 52W High Chg -72.00%
Recommedations 1.00 Quick Ratio 3.24 Shares Outstanding 16.82M 52W Low Chg 35.00%
Insider Own 7.30% ROA -43.02% Shares Float 15.59M Beta -1.04
Inst Own 26.73% ROE -92.05% Shares Shorted/Prior 66.50K/133.45K Price 1.46
Gross Margin 11.47% Profit Margin -117.42% Avg. Volume 41,004 Target Price -
Oper. Margin -196.66% Earnings Date Apr 15 Volume 7,826 Change -2.01%
About Biomerica, Inc.

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Biomerica, Inc. News
04/15/24 Biomerica provides update on inFoods® IBS expansion
04/12/24 Biomerica Reports Third Quarter 2024 Financial Results
03/28/24 Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
02/21/24 Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
01/23/24 Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
01/16/24 Biomerica Reports Second Quarter 2024 Financial Results
12/20/23 Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?
12/18/23 Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
11/10/23 Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
11/08/23 Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
10/13/23 REPEAT - Biomerica Reports First Quarter 2024 Financial Results
10/13/23 Biomerica Reports First Quarter 2024 Financial Results
09/26/23 Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test
09/22/23 Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET.
08/28/23 Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
08/27/23 Biomerica Full Year 2023 Earnings: US$0.50 loss per share (vs US$0.36 loss in FY 2022)
08/25/23 Biomerica Reports Fiscal 2023 Year End Results
08/03/23 CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test
06/21/23 Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
05/18/23 inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology
BMRA Chatroom

User Image nyg123 Posted - 1 day ago

$BMRA With a little over $5 million in cash left and ~$500,000 a month cash burn. They will be out of cash on January 25, 2025. The only option left is dilute existing shareholders by selling more shares. But volume is so low will be difficult without tanking the stock.

User Image Abrahah Posted - 2 days ago

$BMRA Oh yea, what was the previous marking teams big statement.. ”we signed one place up in Texas “ for the ibs.. pityfull. So these new guys are probably starting from ground zero and bringing in some top performers from their previous job life and contending with Zack saying their salary is too high.

User Image Abrahah Posted - 2 days ago

$BMRA Probably the marketing guys, they barely got a mention on their early achievements in the earnings report. These are the guys that will run up the price with their expertise and connections in the marketplace and are salivating when the day comes when there is a buyout and they cash in, handsomely as they have done. The conversation may have went something like this…. Zack,what are you doing, you put out the numbers and all your doctor stuff and barely mention the marketing side. we want some recognition. Zack may be tone deaf, because he surly just insulted his marketing team and it seems they were none too happy. He has never had to deal with an aggressive marketing team, so he and his executive secretary better wise up and treat these guys with the respect they have earned over the life of their career. Zack you are in the ”bigger league” now.

User Image Abrahah Posted - 2 days ago

$BMRA They do an outstanding job of developing new devices to the market. Where they desperately need help is the marketing side. They did just hire two key marketing fellows, maybe it’s their influence on the tone of the latest earnings report. Also there must be pressure coming from somewhere/someone for them to make the recent press release on how IBS is gaining momentum. When i read an earnings statement, i look for what they do not mention and the last report barely touched IBS. Somebody blasted Zack about that and thus the press release.

User Image Abrahah Posted - 2 days ago

$BMRA

User Image ildamiano1 Posted - 2 days ago

$BMRA So with cash of 5.5 million and current annual sales of 4 million, this means that inFoods (which changes lives, and has a potential global market of 800 million IBS sufferers) and the hPylori test is currently valued by the market at a combined 3.5 million dollars! Insanity, which will get corrected. Those coming in now are going to make an absolute packet.

User Image omarrjoob55 Posted - 3 days ago

$BMRA I have a question, did the company have debt?

User Image ildamiano1 Posted - 3 days ago

$BMRA Over 75% of the PM trades today have been purchases at 1 dollar or above! Our kunnt friends naturally have swiftly stepped in with their trademark bs tiny sells to depress the price back to the mid-eighties. Their finger-in-the-dam knapp is going to get blown out of the water when The Big One arrives (total buyout, big hPylori deal or big inFoods deal(s)), and that cannot be far off. Today's IBS update indicates that well - anything that elicits "it changed my life" from anyone is going places. Hang tight, my long amigos! And FORK off, kunnt shorties.

User Image Chuckyboss1 Posted - 3 days ago

$BMRA 5 new patents lots in the works here this is a good Wall Street bet play

User Image Stock_Titan Posted - 3 days ago

$BMRA Biomerica provides update on inFoods® IBS expansion https://www.stocktitan.net/news/BMRA/biomerica-provides-update-on-in-foods-r-ibs-8aea91b5e48y.html

User Image ForkMAN Posted - 4 days ago

$BMRA $1MM in sales for the Quarter. If things were reading up at all, you can bet we would hear about it. Where are the ez detect sales from the U.S.? Did they increase or decrease? We're they even significant? No reporting on it means...non significant, unfortunately!

User Image Abrahah Posted - 5 days ago

$BMRA a whole new reporting tone in this release as compared to others. definate improvements…. not much on ibs??? kinda of like they covid test, which made a ton of money in Europe, never did not find out why they didnot apply for US sales license??? anybody know why?? like i said not much on ibs, wondering wjere thats going, right now it does not seem to be going up because of the silence in the report, while previous reports were blowing the horn and tapping the tambourine about ibs!!

User Image Unvestor Posted - 6 days ago

$BMRA The report came in pretty good. Most metrics showed improvements, such as a reduction in loss per share, more international presence, and their IBS and ELISA tests are moving through the process to release. Someone mentioned the ELISA tests for a bacteria (H pylori) that has no symptoms. It is a precursor to various rectal cancers, rather important I'd think.

User Image Stock_Titan Posted - 6 days ago

$BMRA Biomerica Reports Third Quarter 2024 Financial Results https://www.stocktitan.net/news/BMRA/biomerica-reports-third-quarter-2024-financial-8hndmdora2ef.html

User Image ildamiano1 Posted - 6 days ago

$BMRA Decent bit of PM buying at 84/85 this morning. Q3 earnings will be announced on or before Monday, current price has them marked as disastrously worse than usual, which they won't be - expectation is -0.12 per share, sales of 1.1 million. News of imminent actual commercial value for inFoods is the key.

User Image PatentGrants Posted - 1 week ago

$BMRA Biomerica has received a decision to grant European patent number EP3497447 titled "COMPOSITIONS, DEVICES, AND METHODS OF DEPRESSION SENSITIVITY TESTING". https://register.epo.org/application?number=EP17825010

User Image ildamiano1 Posted - 1 week ago

$BMRA Just to continue to highlight the constant manipulation going on here : 70k shares traded today, 94% above 84 cents (and most of that above 86). Yet you'll see this close at 82 or below with bs final-minute trades. Yes the company is doing its bit by completely mucking up the commercialisation of inFoods thusfar but when that gets sorted by Jack and Gary and Zack, this balloons upwards in a flash.

User Image iNvest4Win Posted - 1 week ago

$BMRA .85, we’ll see if it was a good buy.

User Image deepthinker Posted - 2 weeks ago

$BMRA I haven’t owned this for awhile. It’s probably a merger candidate. I think a larger entity might be able to grow InFoods a lot faster. The rest of their stuff doesn’t have much value.

User Image ildamiano1 Posted - 03/28/24

$BMRA Congratulations arsehole kunnt serial-shorters who needed the Q1 price to end as low as possible. How the market allowed it to happen is a disgrace.

User Image ildamiano1 Posted - 03/28/24

$BMRA Whilst this isn’t The Big One, DDW is a high-profile conference and having U-Mich doing&presenting extensive research on inFoods with (very presumably) great results should help propel it towards the national attention and take-up it deserves.

User Image Stock_Titan Posted - 03/28/24

$BMRA Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference https://www.stocktitan.net/news/BMRA/biomerica-in-foods-ibs-data-to-be-presented-at-the-upcoming-r3626xrdqvz6.html

User Image IntelligunInvestings Posted - 03/26/24

$BMRA why are we dipping lol this is nonsensical The company is doing better

User Image ildamiano1 Posted - 03/22/24

$BMRA I'm totally sick of these situations, but yet again we have a price plunge with no news or volume backing it up. Less than 1% of the company's shares were traded in the last 2 and a half sessions, yet the price has plummeted 24%. Buy the dip yet again I guess.

User Image ildamiano1 Posted - 1 month ago

$BMRA This gives a good example of the current ongoing manipulation. 90% of the most recent shares bought at 1.06 or higher. Current price 1.03. Big bounce back upwards incoming shortly.

User Image ildamiano1 Posted - 1 month ago

$BMRA Our kunnt serial-shorting friends again with the manipulation of the Bid & Ask to bring this down 13% in less than 4 sessions with total volume amounting to way less than 1% of total stock, most of it not their deals. This needs to get hammered with the blowout announcement that we are fcuking ready for.

User Image omarrjoob55 Posted - 1 month ago

$BMRA Booring stock

User Image Scientwist Posted - 1 month ago

$BMRA and Another one! It’s like if I like a company to come on here and write about it.. it’s only a matter of time! I’m jk! He Market can humble you real quick. But this been a heck of a week!

User Image topstockalerts Posted - 02/23/24

$MNPR what a week!! Closing another strong week filled with winners 🏆 $BMRA $PHIO $IFBD and many more 📈 Stay tuned for more alerts!!

User Image IntelligunInvestings Posted - 02/23/24

$BMRA yep this is going to $2 very soon Maybe $5 end of year if we continue with infoods progress

Analyst Ratings
Aegis Capital Buy Oct 19, 20
Aegis Capital Buy Sep 4, 20
Aegis Capital Buy Aug 21, 20
B. Riley Securities Buy Dec 17, 18
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Irani Zackary S. Chief Executive Offi.. Chief Executive Officer May 09 Buy 1.39 300 417 1,017,660 05/10/23
Irani Zackary S. Chief Executive Offi.. Chief Executive Officer Apr 27 Buy 1.33 4,400 5,852 1,017,360 05/01/23
Irani Zackary S. Chief Executive Offi.. Chief Executive Officer Apr 26 Buy 1.26 7,000 8,820 1,012,960 04/27/23
BARBIERI ALLEN Executive Vice Chair.. Executive Vice Chairman Jan 27 Buy 2.94 1,538 4,522 101,327 01/31/23
Coste Catherine Director Director Jan 26 Buy 2.96 2,190 6,482 43,790 01/30/23
Irani Zackary S. Chief Executive Offi.. Chief Executive Officer Jan 25 Buy 2.85 1,800 5,130 1,005,960 01/26/23
Irani Zackary S. Chief Executive Offi.. Chief Executive Officer Jan 24 Buy 2.81 2,000 5,620 1,004,160 01/25/23